EA199800941A1 - THERAPEUTICALLY MEANS CONTAINING OXYGEN ANION-RADICALS AND / OR PRODUCTS OF THEIR SUBSEQUENTAL TURNING AND DIVISION AND THEIR APPLICATION FOR THE TREATMENT OF PARKINSON'S DISEASE - Google Patents
THERAPEUTICALLY MEANS CONTAINING OXYGEN ANION-RADICALS AND / OR PRODUCTS OF THEIR SUBSEQUENTAL TURNING AND DIVISION AND THEIR APPLICATION FOR THE TREATMENT OF PARKINSON'S DISEASEInfo
- Publication number
- EA199800941A1 EA199800941A1 EA199800941A EA199800941A EA199800941A1 EA 199800941 A1 EA199800941 A1 EA 199800941A1 EA 199800941 A EA199800941 A EA 199800941A EA 199800941 A EA199800941 A EA 199800941A EA 199800941 A1 EA199800941 A1 EA 199800941A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- parkinson
- disease
- products
- treatment
- radicals
- Prior art date
Links
- 208000018737 Parkinson disease Diseases 0.000 title abstract 3
- 229910052760 oxygen Inorganic materials 0.000 title abstract 2
- 239000001301 oxygen Substances 0.000 title abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 1
- 206010044565 Tremor Diseases 0.000 abstract 2
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 229940126585 therapeutic drug Drugs 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к кислородным анион-радикалам и/или к терапевтическим препаратам, содержащим продукты их последующего превращения и расщепления, их применению для лечения болезни Паркинсона. Основная цель состоит в понижении или исключении тремора, который является типичным для болезни Паркинсона, но и может также встречаться и при других болезнях, или "старческого" тремора.Отчёт о международном поиске был опубликован 1998.12.23.The invention relates to oxygen anion radicals and / or to therapeutic drugs containing the products of their subsequent transformation and cleavage, their use for the treatment of Parkinson's disease. The main goal is to reduce or eliminate tremor, which is typical for Parkinson's disease, but can also occur in other diseases, or "senile" tremor. The international search report was published 1998.12.23.23.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1997108643 DE19708643C2 (en) | 1997-02-20 | 1997-02-20 | Use of oxygen anion radicals and / or their follow-up and breakdown products for the treatment of Parkinson's disease |
| PCT/DE1998/000518 WO1998036758A2 (en) | 1997-02-20 | 1998-02-17 | Therapeutic agents containing oxygen anion radicals and the use thereof in the treatment of parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA199800941A1 true EA199800941A1 (en) | 1999-06-24 |
| EA001107B1 EA001107B1 (en) | 2000-10-30 |
Family
ID=7822112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA199800941A EA001107B1 (en) | 1997-02-20 | 1998-02-17 | Therapeutic agents containing oxygen anion radicals and/or preparations of their further reaction and breakdown products and the use thereof in the treatment of parkinson's disease. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0910392A2 (en) |
| CN (1) | CN1222856A (en) |
| AU (1) | AU6819898A (en) |
| CA (1) | CA2259986A1 (en) |
| DE (1) | DE19708643C2 (en) |
| EA (1) | EA001107B1 (en) |
| WO (1) | WO1998036758A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10248601B4 (en) * | 2002-10-17 | 2006-05-24 | Goldstein, Naum, Dr.habil.nat. | Pharmaceutical agent for endonasal administration in the treatment of diseases and disorders of the central nervous system |
| RU2253461C1 (en) * | 2004-04-30 | 2005-06-10 | Общество с ограниченной ответственностью "Паркинфарм" | Pharmaceutical combination influencing central nervous system function; method of correcting conditions associated with dysfunction of central nervous system; pharmaceutical kit; agent assisting therapeutical substances and metabolites to cross blood-brain barrier; and endonasal drug |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4112459A1 (en) * | 1991-04-12 | 1992-10-15 | Naum Dr Goldstein | METHOD AND DEVICE FOR PRODUCING DEFINED IONIZED GASES OR. GAS MIXTURES |
| CA2084725A1 (en) * | 1992-02-06 | 1994-06-08 | Albert Roussy | Therapeutic solution for external use |
-
1997
- 1997-02-20 DE DE1997108643 patent/DE19708643C2/en not_active Expired - Fee Related
-
1998
- 1998-02-17 AU AU68198/98A patent/AU6819898A/en not_active Abandoned
- 1998-02-17 EP EP98913515A patent/EP0910392A2/en not_active Withdrawn
- 1998-02-17 CN CN98800497.6A patent/CN1222856A/en active Pending
- 1998-02-17 EA EA199800941A patent/EA001107B1/en not_active IP Right Cessation
- 1998-02-17 CA CA 2259986 patent/CA2259986A1/en not_active Abandoned
- 1998-02-17 WO PCT/DE1998/000518 patent/WO1998036758A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0910392A2 (en) | 1999-04-28 |
| EA001107B1 (en) | 2000-10-30 |
| CA2259986A1 (en) | 1998-08-27 |
| DE19708643A1 (en) | 1998-08-27 |
| AU6819898A (en) | 1998-09-09 |
| WO1998036758A3 (en) | 1998-12-23 |
| WO1998036758A2 (en) | 1998-08-27 |
| DE19708643C2 (en) | 1999-04-15 |
| CN1222856A (en) | 1999-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
| ATE241365T1 (en) | PREPARATIONS CONTAINING SACCHARIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES | |
| RU94038043A (en) | Use of the substituted adenine derivatives for multiple sclerosis treatment | |
| DE69533040D1 (en) | MEDICINES FOR PREVENTING OR TREATING VASCULAR HEMORRHAGIA | |
| EA200100524A1 (en) | AMIDES OF ANTRANILIC ACID AND THEIR APPLICATION AS MEDICINES | |
| NL970006I1 (en) | Use of indolone derivatives for the manufacture of medicines to treat Parkinson's disease. | |
| AU3040995A (en) | Treatment of autoimmune diseases by oral administration of autoantigens | |
| NO306677B1 (en) | Heterocyclic compounds, pharmaceutical preparations and the use of such a compound for the manufacture of a drug | |
| EP1007556A4 (en) | TROPONIN SUBUNITS AND FRAGMENTS USEFUL AS ANGIOGENESIS INHIBITORS | |
| NZ332720A (en) | Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia | |
| DE60042137D1 (en) | RECOMBINANT ALPHA-L-IDURONIDASE AND TREATMENT OF SUFFERED SKIN DISEASES | |
| DE69840909D1 (en) | ANALOG OF COCAINE | |
| ATE217191T1 (en) | USE OF PHANQUINONE TO TREAT ALZHEIMER'S DISEASE | |
| WO2004043373A3 (en) | Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme | |
| EA199800941A1 (en) | THERAPEUTICALLY MEANS CONTAINING OXYGEN ANION-RADICALS AND / OR PRODUCTS OF THEIR SUBSEQUENTAL TURNING AND DIVISION AND THEIR APPLICATION FOR THE TREATMENT OF PARKINSON'S DISEASE | |
| EA200401295A1 (en) | STATIN THERAPY TO ENHANCE SUPPORT OF COGNITIVE FUNCTION | |
| FR2658190B1 (en) | HYDROQUINONE AMINO ACID ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM. | |
| AU7230894A (en) | Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases | |
| MY103593A (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
| ATE147978T1 (en) | USE OF (E)-2-(P-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| DK0703781T3 (en) | Use of Efaroxan and its Derivatives for the Preparation of a Drug to Treat Parkinson's Disease | |
| DE69420574D1 (en) | DERIVATIVES OF THERAPEUTICALLY EFFECTIVE PEPTIDES IN THE BLOOD COLLECTING CASCADE, METHOD FOR THE PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME | |
| PT865278E (en) | USES OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF THERAPEUTICALLY DIFFICULT DISEASES OF SKIN MUCOSITY | |
| NO961180L (en) | Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease | |
| HUP9802142A2 (en) | Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| PC4A | Registration of transfer of a eurasian patent by assignment |